Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other neoplasm 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 5Decitabine 3Carboplatin 3Busulfan 3Radiotherapy 2Endoscopy 2Chemoradiotherapy 2Capecitabine 2sintilimab 1sargramostim 1liposomal doxorubicin 1fludarabine phosphate 1exemestane 1camrelizumab 1alethine 1Watchful Waiting 1Vincristine 1Ultrasonography, Doppler 1Rifampin 1Proton Therapy 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Papanicolaou Test 1Paclitaxel 1Observation 1Mycophenolic Acid 1Methylation 1Mass Spectrometry 1Liver Transplantation 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Rifampin × Other neoplasm × Clear all
NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
40 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡